(19)
(11) EP 4 017 590 A1

(12)

(43) Date of publication:
29.06.2022 Bulletin 2022/26

(21) Application number: 20760394.5

(22) Date of filing: 13.08.2020
(51) International Patent Classification (IPC): 
A61P 29/00(2006.01)
A61P 37/00(2006.01)
A61K 31/506(2006.01)
 A61P 35/00(2006.01)
C07D 471/04(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 29/00; A61P 35/00; A61P 37/00; C07D 471/04
(86) International application number:
PCT/EP2020/072715
(87) International publication number:
WO 2021/032582 (25.02.2021 Gazette 2021/08)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 19.08.2019 GB 201911868

(71) Applicant: Galapagos N.V.
2800 Mechelen (BE)

(72) Inventors:
  • VAN DER PLAS, Steven, Emiel
    2800 Mechelen (BE)
  • MARTINA, Sébastien, Laurent, Xavier
    2800 Mechelen (BE)
  • COTI, Ghjuvanni, Petru, Diunisu
    2800 Mechelen (BE)
  • AMANTINI, David
    93230 Romainville (FR)

(74) Representative: Henry, Neil 
Galapagos NV Generaal De Wittelaan, L11 A3
2800 Mechelen
2800 Mechelen (BE)

   


(54) PYRAZOLO[4,3-C]PYRIDINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS